Webinars » Enhanced Gene Knock-in Efficiency Via non-viral Gene Editing Using CRISPR/Cas Platform | GenScript
With advanced gene editing technology recently introduced, we are privileged to have several cell therapies on current markets. And yet limitations such as toxicity, specificity issues, etc in the process of reprogramming genomes are still present. GenScript has seen those hurdles, and with years of hard work, we developed several tools to disappoint the challenges. Now GenScript provides systemic and efficient sgRNA and DNA cargo manufacturing services and advanced non-viral gene editing CRISPR platform for enhanced knock-in efficiency of your research.
*Presentation will be conducted in Korean language